These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 13671067)

  • 1. [Presence in the erythrocytes of heparin inhibitor].
    BALUDA VP; GORBUNOVA NA
    Biull Eksp Biol Med; 1959 Jun; 47(6):48-51. PubMed ID: 13671067
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of anticoagulants on Plasmodium vivax oocyst development in Anopheles albimanus mosquitoes.
    Solarte Y; Manzano Mdel R; Rocha L; Castillo Z; James MA; Herrera S; Arévalo-Herrera M
    Am J Trop Med Hyg; 2007 Aug; 77(2):242-5. PubMed ID: 17690393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro.
    Lau A; Berry LR; Mitchell LG; Chan AK
    Thromb Res; 2007; 119(6):667-77. PubMed ID: 16793122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of direct toxic and teratogenic effects of anticoagulants on rat embryonic development using in vitro culture method and genotoxicity assay.
    Uysal II; Karabulut AK; Ozdemir K; Aksoy M; Altunkeser BB; Acar H
    Anat Histol Embryol; 2006 Apr; 35(2):84-92. PubMed ID: 16542172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
    Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
    Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From heparins to factor Xa inhibitors and beyond.
    Alban S
    Eur J Clin Invest; 2005 Mar; 35 Suppl 1():12-20. PubMed ID: 15701143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia].
    Gruel Y; Regina S; Pouplard C
    Rev Prat; 2006 Apr; 56(7):710-8. PubMed ID: 16739902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IN VITRO STUDIES ON ERYTHROPHAGOCYTOSIS.
    GREENDYKE RM; BRIERTY RE; SWISHER SN
    Blood; 1963 Sep; 22():295-312. PubMed ID: 14056869
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypersensitivity reaction and Chinese heparin].
    Désormeaux A; Montpas N; Adam A
    Ann Pharm Fr; 2009 May; 67(3):169-72. PubMed ID: 19446665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
    Durand M; Lecompte T; Hacquard M; Carteaux JP
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivessel coronary thrombosis resulting from heparin induced thrombocytopenia.
    Iqbal R; Mulvihill NT; Nolan B; Crean PA
    Ir Med J; 2007 Sep; 100(8):569-71. PubMed ID: 17955717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ANTICOAGULANTS IN THE TREATMENT OF MYOCARDIAL INFARCT].
    DOICHINOV A
    Suvr Med (Sofiia); 1963; 14():30-7. PubMed ID: 14055124
    [No Abstract]   [Full Text] [Related]  

  • 17. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 18. The status of new anticoagulants.
    Bates SM; Weitz JI
    Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antithrombin-based anticoagulants.
    Desai UR
    Med Res Rev; 2004 Mar; 24(2):151-81. PubMed ID: 14705167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
    Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
    Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.